These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15531322)

  • 1. Too thick for your drugs.
    Dreyer EB
    Am J Ophthalmol; 2004 Nov; 138(5):847-8. PubMed ID: 15531322
    [No Abstract]   [Full Text] [Related]  

  • 2. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
    Shimmyo M
    Am J Ophthalmol; 2005 Jun; 139(6):1148; author reply 1148-9. PubMed ID: 15953471
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigation of the biomechanical properties of the cornea in patients with normotensive and primary open-angle glaucoma].
    Avetisov SE; Bubnova IA; Antonov AA
    Vestn Oftalmol; 2008; 124(5):14-6. PubMed ID: 19062550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern alchemy: fixed combinations of glaucoma drugs.
    Katz LJ
    Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653
    [No Abstract]   [Full Text] [Related]  

  • 5. Uniocular drug trials.
    Rotchford AP; King AJ
    Ophthalmology; 2004 Dec; 111(12):2315; author reply 2315-6. PubMed ID: 15582097
    [No Abstract]   [Full Text] [Related]  

  • 6. Uniocular drug trial.
    Jones R; Triana MI; Zaslow K; Sponsel WE
    Ophthalmology; 2005 Jun; 112(6):1170; author reply 1170-1. PubMed ID: 15936449
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical therapy of glaucoma.
    Singh A
    Ophthalmol Clin North Am; 2005 Sep; 18(3):397-408, vi. PubMed ID: 16054997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cornea between constant and parameter in glaucoma diagnosis and treatment].
    Potop V
    Oftalmologia; 2013; 57(3):3-8. PubMed ID: 24701808
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the additive effect of bunazosin on latanoprost in primary open-angle glaucoma.
    Maruyama K; Shirato S; Haneda M
    Jpn J Ophthalmol; 2005; 49(1):61-2. PubMed ID: 15692779
    [No Abstract]   [Full Text] [Related]  

  • 10. Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.
    Bean GW; Camras CB
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S69-84. PubMed ID: 19038626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Open angle glaucoma: risk factors and progression].
    Kriegeskorte V
    Klin Monbl Augenheilkd; 2001 May; 218(5):A84-6. PubMed ID: 11417349
    [No Abstract]   [Full Text] [Related]  

  • 13. Mean standard deviations for common glaucoma treatments.
    Stewart WC; Stewart JA; Nelson LA; Kruft B
    Acta Ophthalmol; 2009 Feb; 87(1):112-4. PubMed ID: 18494738
    [No Abstract]   [Full Text] [Related]  

  • 14. Nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma.
    Costagliola C; Parmeggiani F; Caccavale A; Sebastiani A
    Am J Ophthalmol; 2006 Feb; 141(2):379-81. PubMed ID: 16458700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early aggressive intraocular pressure lowering, target intraocular pressure, and a novel concept for glaucoma care.
    Singh K; Shrivastava A
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S33-8. PubMed ID: 19038622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
    Tugushi OA; Shliapuzhnikova AV; Listopadova NA
    Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Compliance and ignorance in glaucoma in Romanian patients].
    Dumitrica DM; Stefan C
    Oftalmologia; 2009; 53(3):130-3. PubMed ID: 19899560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Steroid induced ocular hypertension and glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2009; 53(3):15-33. PubMed ID: 19899544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Glaucoma Prevention Study.
    Quigley HA
    Ophthalmology; 2005 Sep; 112(9):1642-3; author reply 1643-5. PubMed ID: 16139678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.